Overview

A Multicenter, Randomized, Double-Blind, Controlled Clinical Study of Minocycline for the Treatment of Retinitis Pigmentosa

Status:
NOT_YET_RECRUITING

Trial end date:
2028-06-30

Target enrollment:

Participant gender:

Summary

This is a multicenter, double-blind, randomized controlled clinical trial to get high - level evidence on minocycline's efficacy and safety100mg/d, 200mg/d) for Retinitis pigmentosa and to find the optimal treatment dose.

Phase:

PHASE3

Details

Lead Sponsor:

Zhongshan Ophthalmic Center, Sun Yat-sen University

Treatments:

Minocycline